Mitapivat Impurity 8 | CAS 208175-71-7 - Request Quote
Mitapivat Impurity 8
| SZ CAT No: | SZ-M133012 |
| CAS No | 208175-71-7 |
| Mol.F. | C18H16N2O4S |
| Mol.Wt. | 356.4 |
| Inv. Status | Under QC Approval |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Mitapivat Impurity 8 is chemically Ethyl 4-(quinoline-8-sulfonamido)benzoate. Mitapivat Impurity 8 is supplied with detailed characterization data compliant with regulatory guideline. Mitapivat Impurity 8 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Mitapivat.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 208175-71-7
Purchase 208175-71-7
Order 208175-71-7
Enquire 208175-71-7
price of 208175-71-7
208175-71-7 Supplier
208175-71-7 Manufacturer
208175-71-7 Exporter
buy high quality Mitapivat Impurity 8
Purchase Mitapivat Impurity 8
Mitapivat Impurity 8 suppliers
Mitapivat Impurity 8 manufacturers
Mitapivat Impurity 8 price
Order Mitapivat Impurity 8
Enquire Mitapivat Impurity 8
Mitapivat Impurity 8 cost
Mitapivat Impurity 8 Supplier
Mitapivat Impurity 8 Distributor
Mitapivat Impurity 8 for Method Validation
Mitapivat Reference Standard
Mitapivat Impurity 8 for ANDA Filing
Mitapivat Impurity 8 for Forced Degradation Studies
Mitapivat Impurity 8 Identification Standards
Mitapivat Impurity 8 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


